switching between glp-1 agonists chart glp 1 agonist conversion GLP‐1 receptor in clinical practice: Expert Switching between GLP‐1 receptor agonists

These drugs mimic the effects of the naturally occurring GLP-1 hormone, which is produced in the small intestine and plays a crucial role in regulating insulin secretion, glucose homeostasis, and appetite.

Gastric ultrasound identifies increased residual gastric contents in patients on GLP-1 receptor agonists, showing that shorter drug withholding and fasting times are linked to higher aspiration risk before anesthesia.

In addition to todays resource, please see and review the New York Times article, The Risks of Taking Drugs Like Ozempic When Youre Over 65: Medications that cause drastic weight loss raise specific concerns for older adults

Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain

For best results, we recommend 3-6 months of consistent daily use

Dipeptidyl peptidase 4 inhibitors are now widely used in the treatment of patients with type 2 diabetes mellitus